Literature DB >> 12008692

Triglyceride-induced diabetes mellitus in congenital generalized lipodystrophy.

Renan Magalhães Montenegro1, Ana Paula Dias Rangel Montenegro, Maria Inez Machado Fernandes, Renata Ribeiro de Moraes, Jorge Elias, Leonor Maria Ferreira Braz Gouveia, Valdair Francisco Muglia, Milton Cesar Foss, Ayrton Custódio Moreira, Carlos Eduardo Martinelli.   

Abstract

High levels of triglycerides and free fatty acids have been implicated in the pathogenesis of type 2 diabetes mellitus (DM). Congenital generalized lipodystrophy (CGL) is an autosomal recessive syndrome characterized by intense whole body reduction of subcutaneous fat. Its clinical manifestations appear during the first years of life. However, DM is usually a late event. We report a patient with CGL, diagnosed at 4 months of age, who has severe hypertriglyceridemia (serum triglyceride 12.34 mmol/l and cholesterol 3.90 mmol/l), muscular hypertrophy, hepatomegaly and DM (fasting glycemia 25.9 mmol/l). Hepatic biopsy revealed steatosis and fibrosis. A modified normolipidic (composed of medium chain triglycerides) normocaloric normoproteic milky diet and insulin therapy were instituted. After 1 month treatment a reduction of serum glucose and triglyceride levels (4.13 mmol/I and 7.7 mmol/l, respectively) was noted, with later normalization, which led to the discontinuation of insulin therapy. The patient has been maintaining good control with diet alone, presenting normal serum lipid levels (triglycerides 1.07 mmol/l, total cholesterol 2.71 mmol/l) and the following glycemic profile at OGTT: 0' 4.4 mmol/l; 30' 7.0 mmol/l; 60' 3.8 mmol/l; 90' 5.3 mmol/l, and 120' 5.2 mmol/l. The disappearance of hepatic steatosis was evidenced by a biopsy obtained 1 year after the beginning of treatment. In conolusion, this report suggests that the DM occurring in CGL can be precipitated by high triglyceride levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12008692     DOI: 10.1515/jpem.2002.15.4.441

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  4 in total

Review 1.  Lipodystrophies: adipose tissue disorders with severe metabolic implications.

Authors:  Víctor A Cortés; Marta Fernández-Galilea
Journal:  J Physiol Biochem       Date:  2015-04-02       Impact factor: 4.158

2.  Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice.

Authors:  Hana Koutnikova; Terrie-Anne Cock; Mitsuhiro Watanabe; Sander M Houten; Marie-France Champy; Andreé Dierich; Johan Auwerx
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-05       Impact factor: 11.205

3.  Identification of a novel nonsense mutation and a missense substitution in the AGPAT2 gene causing congenital generalized lipodystrophy type 1.

Authors:  Amirreza Haghighi; Maryam Razzaghy-Azar; Ali Talea; Mahnaz Sadeghian; Sian Ellard; Alireza Haghighi
Journal:  Eur J Med Genet       Date:  2012-08-01       Impact factor: 2.708

4.  Effects of medium chain triglycerides supplementation on insulin sensitivity and beta cell function: A feasibility study.

Authors:  Dylan D Thomas; Mary-Catherine Stockman; Liqun Yu; Tova Meshulam; Ashley C McCarthy; Annaliese Ionson; Nathan Burritt; Jude Deeney; Howard Cabral; Barbara Corkey; Nawfal Istfan; Caroline M Apovian
Journal:  PLoS One       Date:  2019-12-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.